Exclusivity and Confidentiality AgreementExclusivity and Confidentiality Agreement • December 22nd, 2010 • Wonder Holdings, Inc. • Pharmaceutical preparations • Delaware
In connection with your consideration of a possible transaction involving Matrixx Initiatives, Inc. (the “Company”), the Company is prepared to make available to you certain information concerning its business, financial condition, operations, assets, and liabilities. As a condition to such information being furnished to you and your directors, officers, employees, Primus Therapeutics, Inc., agents, or advisors (including, without limitation, your attorneys, accountants, consultants, bankers, and financial advisors) (collectively the “Representatives”), you agree to treat any information concerning the Company (whether prepared by you, your Representatives, or otherwise and irrespective of the form of communication) that has been or will be furnished to you or your Representatives by or on behalf of the Company (herein collectively referred to as the “Evaluation Material”) in accordance with the provisions of this letter agreement, and to take or abstain from taking certain other actio
TENDER AND VOTING AGREEMENTTender and Voting Agreement • February 3rd, 2011 • Wonder Holdings, Inc. • Pharmaceutical preparations • Delaware
This Tender and Voting Agreement, dated as of February 1, 2011 (this “Agreement”), is by and among WONDER HOLDINGS ACQUISITION CORP., a Delaware corporation (“Parent”), WONDER HOLDINGS, INC., a Delaware corporation (“Merger Sub”), and the stockholder of Matrixx Initiatives, Inc., a Delaware corporation (the “Company”), set forth on the signature page hereto (the “Stockholder”). Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Merger Agreement.
SCHEDULE 13D JOINT FILING AGREEMENTJoint Filing Agreement • February 4th, 2011 • Wonder Holdings, Inc. • Pharmaceutical preparations
In accordance with the requirements of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and subject to the limitations set forth therein, the parties set forth below agree to jointly file the Schedule 13D to which this joint filing agreement is attached, and have duly executed this joint filing agreement as of the date set forth below.
